A Phase 4 interventional study of Combined treatment with Arimidex and Zoladex before IVF in Endometriosis, sponsored by Rigshospitalet, Denmark. Completed at 1 site in Denmark. Open to female participants aged 20 Years to 40 Years. Per ClinicalTrials.gov, last updated 2007-04-23.
Sponsored by Rigshospitalet, Denmark · Phase 4, Interventional, and Treatment
Does a combination of Arimidex and Zoladex make endometriomas shrink and how is the following IVF outcome
901 studies on the registry are indexed under Endometriosis; 259 are open to participants now.
This study's enrollment of 20 is below the median of 64 across 525 interventional studies indexed under Endometriosis.
Browse Endometriosis studies →Rigshospitalet, Denmark is the lead sponsor of 1,017 studies on the registry; 183 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
size of endometriomas after 2½ month of combined downregulation
This study is completed, as verified in Apr 2007. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Rigshospitalet, Denmark